|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Investments: | |||||||||||||||||
| Fixed maturity securities: | |||||||||||||||||
| Bonds available-for-sale, at fair value, net of allowance for credit losses of $145 in 2026 and $130 in 2025 (amortized cost: 2026 - $207,436; 2025 - $203,848) | |||||||||||||||||
| Other bond securities | |||||||||||||||||
| Equity securities, at fair value | |||||||||||||||||
| Mortgage and other loans receivable, net of allowance for credit losses of $816 in 2026 and $727 in 2025 | |||||||||||||||||
| Other invested assets (portion measured at fair value: 2026 - $8,560; 2025 - $8,106) | |||||||||||||||||
| Short-term investments, including restricted cash of $3 in 2026 and $4 in 2025 (portion measured at fair value: 2026 - $1,891; 2025 - $1,624) | |||||||||||||||||
| Total investments | |||||||||||||||||
| Cash | |||||||||||||||||
| Accrued investment income | |||||||||||||||||
| Premiums and other receivables, net of allowance for credit losses of $1 in 2026 and $1 in 2025 | |||||||||||||||||
| Reinsurance assets, net of allowance for credit losses | |||||||||||||||||
| Fortitude RE | |||||||||||||||||
| Excluding Fortitude | |||||||||||||||||
| Total reinsurance assets, net of allowance for credit losses | |||||||||||||||||
| Deferred income taxes | |||||||||||||||||
| Current and deferred income taxes | |||||||||||||||||
| Deferred policy acquisition costs and value of business acquired | |||||||||||||||||
| Market risk benefit assets, at fair value | |||||||||||||||||
| Other assets, including restricted cash of $1 in 2026 and $2 in 2025 (portion measured at fair value: 2026 - $472; 2025 - $441) | |||||||||||||||||
| Separate account assets, at fair value | |||||||||||||||||
| Assets held-for-sale | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities: | |||||||||||||||||
| Future policy benefits for life and accident and health insurance contracts | |||||||||||||||||
| Policyholder contract deposits (portion measured at fair value: 2026 - $12,755; 2025 - $12,156) | |||||||||||||||||
| Market risk benefit liabilities, at fair value | |||||||||||||||||
| Other policyholder funds | |||||||||||||||||
| Fortitude Re funds withheld payable (portion measured at fair value: 2026 - $2,988; 2025 - $3,795) | |||||||||||||||||
| Other liabilities (portion measured at fair value: 2026 - $402; 2025 - $322) | |||||||||||||||||
| Short-term debt | |||||||||||||||||
| Consolidated Entities, Excluding Consolidated Investments | |||||||||||||||||
| Total short-term debt | |||||||||||||||||
| Short-term and long-term debt, of which $1,250 in 2026 and $0 in 2025 is short-term debt | |||||||||||||||||
| Consolidated Entities, Excluding Consolidated Investments | |||||||||||||||||
| Debt of consolidated investment entities | |||||||||||||||||
| Total short-term and long-term debt, of which $1,250 in 2026 and $0 in 2025 is short-term debt | |||||||||||||||||
| Debt of consolidated investment entities | |||||||||||||||||
| Consolidated Entities, Excluding Consolidated Investments | |||||||||||||||||
| Debt of consolidated investment entities | |||||||||||||||||
| Separate account liabilities | |||||||||||||||||
| Liabilities held-for-sale | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Corebridge Shareholders' equity: | |||||||||||||||||
| Common stock, $0.01 par value; 2,500,000,000 shares authorized; shares issued: 2024 - 650,189,849 and 2023 648,148,737 | |||||||||||||||||
| Preferred stock and additional paid-in capital, $1 par value and $1,000 liquidation preference | |||||||||||||||||
| Common stock, $0.01 par value; 2,500,000,000 shares authorized; shares issued: 2026 - 650,189,849 and 2025 - 650,189,849 | |||||||||||||||||
| Treasury stock, at cost; 2026 - 209,875,142 shares and 2025 - 153,816,103 shares | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Retained earnings | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Total Corebridge Shareholders' equity | |||||||||||||||||
| Non-redeemable noncontrolling interests | |||||||||||||||||
| Total equity | |||||||||||||||||
| Total liabilities and equity | |||||||||||||||||
| Common stock, shares issued (in shares) | |||||||||||||||||
| Total common stock, shares issued (in shares) | |||||||||||||||||
| Common stock, par value (in dollars per share) | |||||||||||||||||
| Total common stock, par value (in dollars per share) | |||||||||||||||||
| Common stock, shares authorized (in shares) | |||||||||||||||||
| Total common stock, shares authorized (in shares) | |||||||||||||||||
Loading...